|
Quotes & Info
|
| DARA > SEC Filings for DARA > Form 8-K on 27-Sep-2012 | All Recent SEC Filings |
27-Sep-2012
Regulation FD Disclosure
On September 27, 2012, DARA BioSciences, Inc. (the "Company") reported that investors from the Company's April 2012 public offering recently elected to exercise warrants to purchase approximately 1.2 million shares of the Company's common stock. The Company realized net proceeds of approximately $1.2 million as a result of these exercises. The Company further reported that it currently has in excess of $8 million of cash.
|
|